CD38 and Miyoshi myopathy: Beyond MM, the expression of CD38 in other types of cancer, which is generally more heterogeneous than in MM, suggests that [68Ga]Ga‐AJ206 may have a role in selecting those patients that might benefit from CD38 directed therapies.